Lung Cancer Clinical Trials

Showing 701-720 of 4,288 trials

Study Assessing QBS72S For Treating Brain Metastases

NCT05305365

This study is to evaluate the efficacy and safety of QBS72S in participants with advanced, relapsed, metastatic cancer with CNS involvement

Brain MetastasesBreast CancerLung Cancer+2 more

Stanford University21 participantsStarted Aug 2022

Palo Alto, California, United States

Active Not RecruitingNA

SP Thoracic IDE Study

NCT05150210

To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in pulmonary lobectomy, and in thymectomy procedures.

Primary Lung CancerBenign Lung DiseaseThymoma+1 more

Intuitive Surgical32 participantsStarted Jul 2022

Los Angeles, California, United States • Boston, Massachusetts, United States • New York, New York, United States +3 more locations

Active Not RecruitingNA

Testing the Engaged Approach to Lung Cancer Screening

NCT06327074

The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US.

Lung Cancer

University of Colorado, Denver40 participantsStarted Mar 2024

Denver, Colorado, United States

Study Assessing QBS72S For Treating Brain Metastases

SP Thoracic IDE Study

Testing the Engaged Approach to Lung Cancer Screening

Related Searches

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)

Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects

Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC

Benefit Evaluation of Foot Reflexology in Oncology

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Using ctDNA to Determine Therapies for Lung Cancer

Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer

Dupilumab_Metastatic NSCLC

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity